Albright Charles

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 94% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Albright Charles's trades of Editas Medicine Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-17 2020-12-15
PlS Planned sale
21,647 -34.1%
150.19
US$775,337 		21,647 -34.1% 150.19 US$775,337
2020-12-17 2020-12-15
PlS Planned sale
40,488 +0.7%
225.26
US$1,301,373 		40,488 +0.7% 225.26 US$1,301,373
2020-12-17 2020-12-15
PlS Planned sale
9,487 +43.1%
487.94
US$3,640,740 		9,487 +43.1% 487.94 US$3,640,740
2020-12-11 2020-12-09
PlS Planned sale
10,000 -28.6%
45.00
US$450,000 		10,000 -28.6% 45.00 US$450,000
2020-12-08 2020-12-07
PlS Planned sale
20,000 -44.5%
40.02
US$800,400 		20,000 -44.5% 40.02 US$800,400
2020-11-10 2020-11-09
S Sale
228 -0.9%
31.21
US$7,116 		228 -0.9% 31.21 US$7,116
2020-10-16 2020-10-15
PlS Planned sale
3,000 -10.7%
31.39
US$94,170 		3,000 -10.7% 31.39 US$94,170
2020-08-19 2020-08-17
PlS Planned sale
10,000 -26.2%
35.29
US$352,900 		10,000 -26.2% 35.29 US$352,900
2020-08-10 2020-08-07
S Sale
238 -0.8%
34.99
US$8,328 		238 -0.8% 34.99 US$8,328
2020-08-10 2020-08-06
PlS Planned sale
10,000 -26.1%
37.47
US$374,700 		10,000 -26.1% 37.47 US$374,700
2020-07-17 2020-07-15
PlS Planned sale
3,000 -9.6%
32.22
US$96,660 		3,000 -9.6% 32.22 US$96,660
2020-05-08 2020-05-06
S Sale
151 -0.5%
25.28
US$3,817 		151 -0.5% 25.28 US$3,817
2020-02-10 2020-02-07
S Sale
622 -1.9%
26.95
US$16,763 		622 -1.9% 26.95 US$16,763
2020-02-04 2020-02-03
S Sale
5,549 -21.3%
26.54
US$147,288 		5,549 -21.3% 26.54 US$147,288